Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Article · 30 Apr 2025 Conference abstract Improving compliance with EMA and FDA pediatric regulations by improving the efficiency of pediatric drug development
While the list of unmet needs in child-appropriate drugs remains long
Perspective · 28 Mar 2025 Enhancing Pharmaceutical Manufacturing through Process Analytical Technology
Process Analytical Technology (PAT) is a framework established by the U.S. Food
Conference abstract · 28 Sep 2016 Pharmacovigilance and compliance of drugs labeling information with the 2015 FDA Lactation Guidelines
information (PI) for commonly prescribed drugs in the USA, and to examine compliance with the new 2015 FDA labeling guidelines. Data were also compared to the authors’ previously published information ... included a…
Conference abstract Pharmacovigilance and compliance of drugs labeling information with the 2015 FDA lactation guidelines
information (PI) for commonly prescribed drugs in the USA, and to examine compliance with the new 2015 FDA labeling guidelines. Data were also compared to the authorsâ?? previously published information ... included a…
Conference abstract · 13 Jul 2015 Herpes Zoster: Conundrums and controversies
currently recommended in patients over 50, and very few surveys have evaluated patient compliance since its FDA approval. In current clinical settings, it is unclear who should be taking
Conference abstract Seafood inspection process by The United States Food and Drug Administration
priority for the United States Food and Drug Administration (FDA). To determine compliance with FDA laws and regulations, the FDA conducts import field examinations and sample collections of food products
Conference abstract · 21 Oct 2013 Adherence to IEC62366 may not ensure a successful FDA review: A case study
adheres to 62366. And it has become common for manufacturers to submit such compliance to the FDA for US release; especially for those attempting to enter the US market after ... error. Through a case study, this…
Conference abstract · 25 Sep 2014 Effective CAPA Program, A valuable tool in quality improvement
Preventive Action (CAPA) can improve the quality of products and may reduce the compliance risk. FDA warning letters have cited deficient CAPA program as one of the major compliance weak
Review article · 2013 The 7th System: Integrating Clinical Systems into a Comprehensive Quality Audit Program
failure to provide adequate oversight of an organization’s overall compliance. Using FDA’s six-system inspection model as a starting point, this article will discuss how to integrate
Research article · Dec 2021 GMP Compliance for Sterile Drug Products: A Regulatory Prospectives
site of sterile drug products as part of the cGMP compliance verification. Due to the violation of cGMP the FDA issued more warning letters and form 483 to finish product ... describing the cause for non-compliance, and…
Research article · 26 Dec 2022 Bioequivalence Study of a Novel Clobetasol Propionate Topical gel 0.05% using the Vasoconstriction Bioassay
versus a marketed reference cream to test their in vivo bioequivalence in compliance with FDA guidance. The pilot part determined the dose-duration response curve to the reference. The pivotal
Conference abstract Specialized US Food and Drug Administration investigators for enhanced protection of public health
manufacturing, food processing, or bioresearch monitoring (human subject protection, clinical trial data reliability, compliance with US FDA postmarketing safety regulations). Increased specialization and dedication of…
Review article · 11 Nov 2023 FDA Warning Letters, Consequences and Costs to the US Medical Device Industry
related to medical device CAPA and the associated costs of remediation for non-compliance with the FDA. This study delves into the costs and issues related to medical device companies
Conference abstract · 25 Sep 2017 Regulatory affairs
enforcement matters. While the RPM is intended mainly to provide guidance to FDA inspectors, investigators, and compliance officers, the document is useful to all of FDA. Career Development in Regulatory
Conference abstract · 26 Oct 2015 Good Manufacturing Practices: The Gap within
ensures that products are consistently produced and controlled according to quality standards as per FDA. GMP is designed to minimize the risks involved in any pharmaceutical production that cannot ... manufacture the…
Conference abstract United States Food and Drug Administration Postmarketing Adverse Drug Experience (PADE) inspections and the most frequently cited deviations from federal regulations
United States (US) Food and Drug Administration (FDA)â??s Center for Drug Evaluation and Research (CDER) Office of Compliance (OC) Postmarketing Adverse Drug Experience (PADE) team helps promote ... timeline of…
Conference abstract · 27 Aug 2014 Genetic addiction risk score (GARSrx), comprehensive analysis of reported drugs (CARD) dopamine agonist therapy (kb220z): Embracing genetic prediction of addiction risk severity for pain and addiction treatment
stratification of genetic addiction risk and scientifically accurate drug urine analysis; monitoring for compliance (Comp) to FDA approved medication(s) and abstinence (Abs) from drugs of abuse. Resting state functional
Conference abstract · 27 Aug 2014 Genetic addiction risk score (GARSrx), comprehensive analysis of reported drugs (CARD) dopamine agonist therapy (kb220z): Embracing genetic prediction of addiction risk severity for pain and addiction treatment
stratification of genetic addiction risk and scientifically accurate drug urine analysis; monitoring for compliance (Comp) to FDA approved medication(s) and abstinence (Abs) from drugs of abuse. Resting state functional
Conference abstract · 21 Oct 2013 A cost-effective and practical approach to risk-based computerized system validation (CSV) for pharmaceutical and medical devices regulated environments
product quality, patient safety, data integrity and support of business processes ? Ensuring compliance with EU/ FDA regulations ? Managing the risk associated with potential failures ? Adapting the rigor and intensity
Conference abstract · 12 Nov 2013 What really matters to FDA and why? A comprehensive review & analysis of FDA enforcement action on automated system validation
achieve business objective and meet compliance requirements at the same time. This presentation presents research and review findings and trending analysis from the common FDA enforcement actions such ... Part 11. These…
Conference abstract · 23 Nov 2012 Essentials of GAMP-5: A quality risk-based approach to compliant GxP computerized systems
bodies had made significant updates in their thinking and approach to regulatory compliance. These changes include; ? FDA cGMPs for the 21st Century initiative and associated guidance promoting science-based risk
Research article · 2016 Beyond the Web: A Decentralised Approach to Data Collection from Multi- Centric Clinical Trials by Virtual Organizations Using Peer-To-Peer Data Sharing
data are an essential part of quality control for regulatory compliance of clinical data collection tasks. FDA CFR 21 part 11, which is an important regulation for clinical trials, explicitly
Conference abstract · 12 Nov 2013 QA inspection
high quality standards directly impacts public health and safety. In the FDA and ISO environments, audit ? both compliance and performance is critical. The audit process is closely associated with quality
Conference abstract · 30 Jun 2016 Liposome Encapsulated Deferoxamine is a More Effective Iron Chelator than Desferal® in an Iron Overloaded Mouse Model
Jadenu® both have black box warnings from the FDA related to renal failure, hepatic failure and GI hemorrhage. Patient compliance is the greatest problem with current chelation therapies. We have

